These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5237174)

  • 21. Synthesis of 9-(2-deoxy-beta-D-ribofuranosyl)purine-2-thione.
    Rappaport HP
    Nucleosides Nucleotides Nucleic Acids; 2000 Apr; 19(4):839-43. PubMed ID: 10960040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleic acids. 12. Synthesis of the L enantiomer of 1- -arabinofuranosylcytosine and of O 2 ,O 2' -anhydro-1- -D-arabinofuranosylcytosine.
    Gish DT; Neil GL; Wechter WJ
    J Med Chem; 1971 Sep; 14(9):882-3. PubMed ID: 5140018
    [No Abstract]   [Full Text] [Related]  

  • 23. Antitumor activity of 5-formamido-1- D-ribofuranosylthioimidazole-4-carboxamide 2',3',5'-triformate in a variety of animal tumors.
    Hoshi A; Kanzawa F; Kuretani K
    Cancer Chemother Rep; 1971 Jun; 55(3):229-31. PubMed ID: 5115844
    [No Abstract]   [Full Text] [Related]  

  • 24. Pyrimidine nucleosides. 5. Syntheses of carcinostatic halogenocyclonucleosides.
    Kanai T; Ichino M; Hoshi A; Kanzawa F; Kuretani K
    J Med Chem; 1972 Dec; 15(12):1218-21. PubMed ID: 4635963
    [No Abstract]   [Full Text] [Related]  

  • 25. Analogs of 6-methyl-9-beta-D-ribofuranosylpurine.
    Montgomery JA; Hewson K
    J Med Chem; 1968 Jan; 11(1):48-52. PubMed ID: 5637189
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and antileukemic activity of certain D-fucopyranosyl nucleosides.
    Lerner LM; Mennitt G; Gaetjens E; Sheid B
    Carbohydr Res; 1993 Jun; 244(2):285-94. PubMed ID: 8348553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of 6-N-hydroxylamino-9-beta-D-ribofuranosylpurine in mouse leukemia.
    Burchenal JH; Dollinger M; Butterbaugh J; Stoll D; Giner-Sorolla A
    Biochem Pharmacol; 1967 Mar; 16(3):423-8. PubMed ID: 6034363
    [No Abstract]   [Full Text] [Related]  

  • 28. Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides: synthesis and biological activity.
    Cristalli G; Vittori S; Eleuteri A; Grifantini M; Volpini R; Lupidi G; Capolongo L; Pesenti E
    J Med Chem; 1991 Jul; 34(7):2226-30. PubMed ID: 2066996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purine nucleosides. XXI. The synthesis of 6-amino-2-methylthio-7-(beta-D-ribofuranosyl)purine, an anomer of the nucleoside from Factor F, by ring closure of an imidazole nucleoside.
    Rousseau RJ; Townsend LB
    J Org Chem; 1968 Jul; 33(7):2828-30. PubMed ID: 5742847
    [No Abstract]   [Full Text] [Related]  

  • 30. Antitumor effect and mode of action of 1-beta-D-arabinofuranosylcytosine 5'-phosphate in leukemia L1210.
    Schrecker AW; Goldin A
    Cancer Res; 1968 Apr; 28(4):802-3. PubMed ID: 5649067
    [No Abstract]   [Full Text] [Related]  

  • 31. Synthesis and biological evaluation of N4-substituted imidazo- and v-triazolo[4,5-d]pyridazine nucleosides.
    Bussolari JC; Ramesh K; Stoeckler JD; Chen SF; Panzica RP
    J Med Chem; 1993 Dec; 36(25):4113-20. PubMed ID: 8258836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aminopyrimidines and derivatives. XXI. Synthesis of 5-acyl(4-beta-D-glycopyranosylamino)pyrimidine derivatives as potential anticancer agents.
    Negrillo J; Nogueras M; Sánchez A; Melgarejo M
    Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):386-93. PubMed ID: 3378299
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis and biological activity of selected 2,6-disubstituted-(2-deoxy- -and- -D-erythro-pentofuranosyl)purines.
    Christensen LF; Broom AD; Robins MJ; Bloch A
    J Med Chem; 1972 Jul; 15(7):735-9. PubMed ID: 4625489
    [No Abstract]   [Full Text] [Related]  

  • 34. The treatment of experimental mouse hemoblastosis IV. Thearapy of leukemia L 14 AKR with drugs of demonstrated or potential cytostatic effects.
    Motycka K; Soucek J
    Neoplasma; 1965; 12(5):517-24. PubMed ID: 4159186
    [No Abstract]   [Full Text] [Related]  

  • 35. Synthetic nucleosides and nucleotides. I. On synthesis and properties of several thiocyanate derivatives of purines and their ribonucleosides.
    Saneyoshi M; Chihara G
    Chem Pharm Bull (Tokyo); 1967 Jul; 15(7):909-14. PubMed ID: 5583152
    [No Abstract]   [Full Text] [Related]  

  • 36. Sulfinosine congeners: synthesis and antitumor activity in mice of certain N9-alkylpurines and purine ribonucleosides.
    Hanna NB; Bhattacharya BK; Robins RK; Avery TL; Revankar GR
    J Med Chem; 1994 Jan; 37(1):177-83. PubMed ID: 8289192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitrosoureidonucleosides.
    Montgomery JA; Thomas HJ
    J Med Chem; 1979 Sep; 22(9):1109-13. PubMed ID: 490557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of certain [6:5:6] linear tricyclic nucleosides as potential antitumor agents.
    Chung FL; Schram KH; Panzica RP; Earl RA; Wotring LL; Townsend LB
    J Med Chem; 1980 Nov; 23(11):1158-66. PubMed ID: 7452664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological activity of some 8-aza-9-cyclopentylpurines.
    Chang PK; Sciarini LJ; Sartorelli AC; Zedeck MS
    J Med Chem; 1968 May; 11(3):513-5. PubMed ID: 4872193
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of 3'-amino-3'-deoxythymidine on L1210 and P388 leukemias in mice.
    Lin TS; Fischer PH; Prusoff WH
    Biochem Pharmacol; 1982 Jan; 31(1):125-8. PubMed ID: 7059345
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.